Editor's Note :

Editor's Note :

The court will be issuing opinions on Friday at 10 a.m. We will begin live-blogging at 9:30 a.m.
Our first interim Stat Pack for October Term 2016, prepared by Kedar Bhatia, is available at this link.
The Supreme Court proceedings and orders in the legal challenges to the administration’s entry ban are available at this link.

Louisiana Wholesale Drug Co. v. Bayer AG

Petition for certiorari denied on March 7, 2011
Docket No. Op. Below Argument Opinion Vote Author Term
10-762 2d Cir. N/A N/A N/A N/A OT 2010

Issue: Whether, absent patent fraud or sham litigation, a brand drug maker's substantial payment to a competing generic drug maker to forgo judicial testing of the patent and restrict entry is per se lawful under the Sherman Act.

Briefs and Documents

Certiorari-stage documents

 
Share:
Term Snapshot
Awards